Home Pharmaceuticals Dementia Drugs Market Size to Grow at a CAGR of 7.95% by 2030

Dementia Drugs Market

Dementia Drugs Market Size, Share & Trends Analysis Report By Indications (Lewy Body Dementia, Parkinsons Disease Dementia, Alzheimers Disease, Vascular Dementia, Other Indications), By Drug Class (MAO-B Inhibitors, Glutamate Inhibitors, Cholinesterase Inhibitors) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2022-2030

Report Code: SRPH3368DR
Study Period 2018-2030 CAGR 7.95%
Historical Period 2018-2020 Forecast Period 2022-2030
Base Year 2021 Base Year Market Size USD 13.40 Billion
Forecast Year 2030 Forecast Year Market Size USD 26.68 Billion
Largest Market Europe  Fastest Growing Market North America
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Dementia Drugs Market, By Indications (2020-2030)
    1. Lewy Body Dementia
    2. Parkinsons Disease Dementia
    3. Alzheimers Disease
    4. Vascular Dementia
    5. Other Indications
  2. Dementia Drugs Market, By Drug Class (2020-2030)
    1. MAO-B Inhibitors
    2. Glutamate Inhibitors
    3. Cholinesterase Inhibitors
    1. North America
      1. North America Dementia Drugs Market, By Indications
        1. Lewy Body Dementia
          1. Parkinsons Disease Dementia
            1. Alzheimers Disease
              1. Vascular Dementia
                1. Other Indications
                2. North America Dementia Drugs Market, By Drug Class
                  1. MAO-B Inhibitors
                    1. Glutamate Inhibitors
                      1. Cholinesterase Inhibitors
                      2. U.S.
                        1. U.S. Dementia Drugs Market, By Indications
                          1. Lewy Body Dementia
                            1. Parkinsons Disease Dementia
                              1. Alzheimers Disease
                                1. Vascular Dementia
                                  1. Other Indications
                                  2. U.S. Dementia Drugs Market, By Drug Class
                                    1. MAO-B Inhibitors
                                      1. Glutamate Inhibitors
                                        1. Cholinesterase Inhibitors
                                      2. Canada
                                    2. Europe
                                      1. Europe Dementia Drugs Market, By Indications
                                        1. Lewy Body Dementia
                                          1. Parkinsons Disease Dementia
                                            1. Alzheimers Disease
                                              1. Vascular Dementia
                                                1. Other Indications
                                                2. Europe Dementia Drugs Market, By Drug Class
                                                  1. MAO-B Inhibitors
                                                    1. Glutamate Inhibitors
                                                      1. Cholinesterase Inhibitors
                                                      2. U.K.
                                                        1. U.K. Dementia Drugs Market, By Indications
                                                          1. Lewy Body Dementia
                                                            1. Parkinsons Disease Dementia
                                                              1. Alzheimers Disease
                                                                1. Vascular Dementia
                                                                  1. Other Indications
                                                                  2. U.K. Dementia Drugs Market, By Drug Class
                                                                    1. MAO-B Inhibitors
                                                                      1. Glutamate Inhibitors
                                                                        1. Cholinesterase Inhibitors
                                                                      2. Germany
                                                                      3. France
                                                                      4. Spain
                                                                      5. Italy
                                                                      6. Russia
                                                                      7. Nordic
                                                                      8. Benelux
                                                                      9. Rest of Europe
                                                                    2. APAC
                                                                      1. APAC Dementia Drugs Market, By Indications
                                                                        1. Lewy Body Dementia
                                                                          1. Parkinsons Disease Dementia
                                                                            1. Alzheimers Disease
                                                                              1. Vascular Dementia
                                                                                1. Other Indications
                                                                                2. APAC Dementia Drugs Market, By Drug Class
                                                                                  1. MAO-B Inhibitors
                                                                                    1. Glutamate Inhibitors
                                                                                      1. Cholinesterase Inhibitors
                                                                                      2. China
                                                                                        1. China Dementia Drugs Market, By Indications
                                                                                          1. Lewy Body Dementia
                                                                                            1. Parkinsons Disease Dementia
                                                                                              1. Alzheimers Disease
                                                                                                1. Vascular Dementia
                                                                                                  1. Other Indications
                                                                                                  2. China Dementia Drugs Market, By Drug Class
                                                                                                    1. MAO-B Inhibitors
                                                                                                      1. Glutamate Inhibitors
                                                                                                        1. Cholinesterase Inhibitors
                                                                                                      2. Korea
                                                                                                      3. Japan
                                                                                                      4. India
                                                                                                      5. Australia
                                                                                                      6. Taiwan
                                                                                                      7. South East Asia
                                                                                                      8. Rest of Asia-Pacific
                                                                                                    2. Middle East and Africa
                                                                                                      1. Middle East and Africa Dementia Drugs Market, By Indications
                                                                                                        1. Lewy Body Dementia
                                                                                                          1. Parkinsons Disease Dementia
                                                                                                            1. Alzheimers Disease
                                                                                                              1. Vascular Dementia
                                                                                                                1. Other Indications
                                                                                                                2. Middle East and Africa Dementia Drugs Market, By Drug Class
                                                                                                                  1. MAO-B Inhibitors
                                                                                                                    1. Glutamate Inhibitors
                                                                                                                      1. Cholinesterase Inhibitors
                                                                                                                      2. UAE
                                                                                                                        1. UAE Dementia Drugs Market, By Indications
                                                                                                                          1. Lewy Body Dementia
                                                                                                                            1. Parkinsons Disease Dementia
                                                                                                                              1. Alzheimers Disease
                                                                                                                                1. Vascular Dementia
                                                                                                                                  1. Other Indications
                                                                                                                                  2. UAE Dementia Drugs Market, By Drug Class
                                                                                                                                    1. MAO-B Inhibitors
                                                                                                                                      1. Glutamate Inhibitors
                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                      2. Turkey
                                                                                                                                      3. Saudi Arabia
                                                                                                                                      4. South Africa
                                                                                                                                      5. Egypt
                                                                                                                                      6. Nigeria
                                                                                                                                      7. Rest of MEA
                                                                                                                                    2. LATAM
                                                                                                                                      1. LATAM Dementia Drugs Market, By Indications
                                                                                                                                        1. Lewy Body Dementia
                                                                                                                                          1. Parkinsons Disease Dementia
                                                                                                                                            1. Alzheimers Disease
                                                                                                                                              1. Vascular Dementia
                                                                                                                                                1. Other Indications
                                                                                                                                                2. LATAM Dementia Drugs Market, By Drug Class
                                                                                                                                                  1. MAO-B Inhibitors
                                                                                                                                                    1. Glutamate Inhibitors
                                                                                                                                                      1. Cholinesterase Inhibitors
                                                                                                                                                      2. Brazil
                                                                                                                                                        1. Brazil Dementia Drugs Market, By Indications
                                                                                                                                                          1. Lewy Body Dementia
                                                                                                                                                            1. Parkinsons Disease Dementia
                                                                                                                                                              1. Alzheimers Disease
                                                                                                                                                                1. Vascular Dementia
                                                                                                                                                                  1. Other Indications
                                                                                                                                                                  2. Brazil Dementia Drugs Market, By Drug Class
                                                                                                                                                                    1. MAO-B Inhibitors
                                                                                                                                                                      1. Glutamate Inhibitors
                                                                                                                                                                        1. Cholinesterase Inhibitors
                                                                                                                                                                      2. Mexico
                                                                                                                                                                      3. Argentina
                                                                                                                                                                      4. Chile
                                                                                                                                                                      5. Colombia
                                                                                                                                                                      6. Rest of LATAM

                                                                                                                                                                  Related Reports

                                                                                                                                                                  Global Report
                                                                                                                                                                  The global dermatological drugs market size was valued at USD 17.09 billion in 2021, and it is anticipated to reach USD 37.85 billion by 2030 at a CAGR of 10.45% during the forecast period(2022-2030). The primary focus of the medical speciality known
                                                                                                                                                                  Buy Now

                                                                                                                                                                  Purchase Benefits

                                                                                                                                                                  • Eligible for a free updated report next year
                                                                                                                                                                  • Completely customizable scope
                                                                                                                                                                  • 30% discount on your next purchase
                                                                                                                                                                  • Dedicated account manager
                                                                                                                                                                  • Query resolution within 24 hours
                                                                                                                                                                  • Permission to print the report


                                                                                                                                                                  We are featured on :